stella
beta
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer — Stella
Recruiting
Back to Anatomic Stage III Breast Cancer AJCC v8 trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(2 sites)
United States
Siteman Cancer Center at Washington University, St Louis, Missouri
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington
View full record on ClinicalTrials.gov